Welcome Guest | Register / Login

Coronavirus Disease 2019 (COVID-19) Clinical Trials - Overview, Landscape, Trial using Vaccines vs. Therapeutics,and Trials Impacted by COVID-19

Table of Contents
Executive Summary
Introduction
Analysis of COVID-19 Clinical Trials
COVID-19 Clinical Trials for Vaccines
COVID-19 Clinical Trials for Therapeutics
Impact of COVID-19 on Clinical Trials
Key Findings
Appendix

List of Tables
Table 1: Top Countries with COVID-19 Key Stats

List of Figures
Figure 1: Impact of COVID-19
Figure 2: Top Countries in COVID-19 Key Stats
Figure 3: Landscape of Pipeline Candidates for COVID-19, by Phase
Figure 4: Landscape of Vaccines Candidates for COVID-19, by Phase
Figure 5: Number of COVID-19 Clinical Trials by Start Date, by Month
Figure 6: Number of COVID-19 Clinical Trials, by Multinational vs. Single Country
Figure 7: Single Country COVID-19 Clinical Trials, By Region & Phase
Figure 8: Multinational Country COVID-19 Clinical Trials, By Region & Phase
Figure 9: COVID-19 Clinical Trial Sites, by Region
Figures 10 & 11: COVID-19 Clinical Trial Sites, by Country & State
Figures 12 & 13: Number of COVID-19 Clinical Trials, by Phase & Status
Figure 14: Endpoint Status for Completed COVID-19 Clinical Trials
Figure 15: Top Reasons for Terminated Trials, by Phase
Figure 16: Top Reason for Terminated Trials, by Sponsor Type
Figure 17: COVID-19 Clinical Trials by Vaccine, by Month
Figures 18 & 19: Vaccine COVID-19 Clinical Trials, by Phase & Status
Figure 20: Vaccine COVID-19 Clinical Trials, by Sponsor Type
Figure 21: Top Industry Sponsors for COVID-19 Vaccine Clinical Trials
Figure 22: Top Non-Industry Sponsors for COVID-19 Vaccine Clinical Trials
Figures 23 & 24: Pfizer/BioNTech's Tozinameran (Comirnaty), by Status & Phase
Figures 25 & 26: Moderna's mRNA-1273, by Status & Phase
Figures 27 & 28: Johnson & Johnson's JNJ-78436735, by Status & Phase
Figures 29 & 30: AstraZeneca's Covishield (Vaxzevria), by Status & Phase
Figures 31 & 32: Bharat Biotech's Covaxin, by Status & Phase
Figures 33 & 34: CanSino Biologics' Convidecia, by Status & Phase
Figures 35 & 36: SinoVac Biotech's CoronaVac, by Status & Phase
Figure 37: Upcoming Filings and Regulatory Approvals for COVID-19 Vaccines
Figure 38: Clinical Trial Start Date to First Approval for Vaccines
Figure 39: COVID-19 Therapeutic Clinical Trials, by Month
Figure 40 & 41: Therapeutic COVID-19 Clinical Trials, by Phase & Status
Figure 42: Therapeutic COVID-19 Clinical Trials, by Sponsor Type
Figure 43: Top Industry Sponsors for COVID-19 Therapeutic Clinical Trials
Figure 44: Top Non-Industry Sponsors for COVID-19 Therapeutic Clinical Trials
Figures 45 & 46: Gilead Sciences' Remdesivir (Veklury), by Status & Phase
Figures 47 & 48: Fujifim Toyama Chemical's Favipiravir, by Status & Phase
Figures 49 & 50: Eli Lilly's Bamlanivimab, by Status & Phase
Figures 51 & 52: Regeneron's Casirivimab + Imdevimab, by Status & Phase
Figures 53 & 54: Eli Lilly's Baricitinib, by Status & Phase
Figures 55 & 56: CytoDyn's Leronlimab, by Status & Phase
Figure 57: Upcoming Filings and Regulatory Approvals for Therapeutic COVID-19 Drugs
Figure 58: Clinical Trials Disrupted Due to COVID-19
Figures 59 & 60: Disrupted Clinical Trials, by Reason
Figure 61 & 62: Disrupted Clinical Trials, by Therapy Area
Figure 63: Disrupted Clinical Trials Activities
Figure 64: Disrupted Clinical Trials, by Top Sponsors
Figure 65: Resumed Clinical Trials, by Top Five Therapy Areas
Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Site License: Report will be emailed in PDF and  allows only employees within the same geographical location within the organization to access it. This License type allows the report to be Printed.
Global Site License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :GlobalData
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy